newratings.com  Nov 7  Comment 
WASHINGTON (dpa-AFX) - ArQule Inc. (ARQL) Monday announced a wider net loss in the third quarter to $5.82 million or $.08 per share compared to $2.354 million or $0.04 per share last year. On average, 4 analysts polled by Thomson Reuters...
newratings.com  Jun 23  Comment 
WASHINGTON (dpa-AFX) - ArQule, Inc. (ARQL) Thursday said it plans to present the preliminary data from the ongoing phase 2 portion of a phase 1/2 trial in intrahepatic cholangiocarcinoma with proprietary fibroblast growth factor receptor...
newratings.com  Jun 9  Comment 
WASHINGTON (dpa-AFX) - ArQule, Inc. (ARQL) Thursday said its preliminary clinical data for ARQ 087 demonstrated anti-cancer activity in Intrahepatic Cholangiocarcinoma, a rare liver cancer with a high mortality rate and limited treatment options....



Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki